Prognostic Impact of CD163+ Macrophages in Tumor Stroma and CD8+ T-Cells in Cancer Cell Nests in Invasive Extrahepatic Bile Duct Cancer

Takuya Miura, Tadashi Yoshizawa, Hideaki Hirai, Hiroko Seino, Satoko Morohashi, Yunyan Wu, Taiichi Wakiya, Norihisa Kimura, Daisuke Kudo, Keinosuke Ishido,

Anticancer Research · 2017 · 60 citations · 17 references

DOIFull text

Open access

Concepts

Abstract

Aim: The aim of this study was to examine the clinicopathological influence of tumor-infiltrating cluster of differentiation (CD) 163<sup>+</sup> macrophages and CD8<sup>+</sup> T-cells, and to clarify the prognostic effects of these cells in patients with invasive extrahepatic bile duct cancer (EHBC). Materials and Methods: The numbers of CD8<sup>+</sup> T-cells in cancer cell nests and CD163<sup>+</sup> macrophages in tumor stroma were evaluated using immunohistochemistry in 101 resected EHBC specimens. Correlations with clinicopathological variables and overall survival were analyzed. Results: Perihilar EHBC and perineural invasion were significantly associated with a low number of tumor-infiltrating CD8<sup>+</sup> T-cells. Poorly- differentiated histology and nodal metastasis were significantly associated with a high number of tumor-infiltrating CD163<sup>+</sup> macrophages. A combination of high number of CD8<sup>+</sup> T-cells and low number of CD163<sup>+</sup> macrophages was independently related to better overall survival in the whole patient cohort (hazard ratio=0.127, p&lt;0.001) and in patients treated with adjuvant chemotherapy (hazard ratio=0.139, p=0.021). Conclusion: Infiltrating CD163<sup>+</sup> macrophages in tumor stroma and CD8<sup>+</sup> T-cells in cancer cell nests have a prognostic impact in patients with EHBC following resection and also after adjuvant chemotherapy.

References

17